Skip to main content
Have a personal or library account? Click to login
Institutional framework for integrated Pharmaceutical Benefits Management: results from a systematic review Cover

Institutional framework for integrated Pharmaceutical Benefits Management: results from a systematic review

Open Access
|Sep 2015

References

  1. InterQuality Project – International Research Project on Financing Quality in Healthcare” funded by the 7th Framework Programme (FP7) for Research and Technological Development (FP7) of the European Union. Grant Agreement No: HEALTH-F3-2010-261369 December 2010 – April 2014. Available from: http://www.interqualityproject.eu
  2. WHO How to develop and implement a national drug policy 2001 2nd ed Geneva 83 [cited 2015 Jan 3]. Available from: http://apps.who.int/medicinedocs/pdf/s2283e/s2283e.pdf
  3. Polish Ministry of Health State's drug policy 2004 – 2008 2004 Warszawa [cited 2015 Jan 3]. Available from: http://www2.mz.gov.pl/wwwfiles/ma_struktura/docs/plekp2004_2008_230304.pdf
  4. McGuire T Bauhoff S Klusen N Verheyen F Wagner C Adoption of a cost-saving innovation: Germany, UK and Simvastatin England and Germany in Europe – What lessons can we learn from each other? 2011 Baden-Baden, Germany NomosVerlag 11 26 [cited 2015 Jan 3]. Available from: http://scholar.harvard.edu/files/bauhoff/files/mcguire_bauhoff_costsavinginnovation.pdf
  5. Office of Fair Trading The pharmaceutical price regulation scheme. An OFT market study 2007 London OFT [cited 2015 Jan 4]. Available from: http://webarchive.nationalarchives.gov.uk/20140402142426/http://www.oft.gov.uk/shared_oft/reports/comp_policy/oft885.pdf
  6. Solow BK Pharmacy benefit management (PBM) in the United States: naughty or nice? ISPOR 16th Annual European Congress 2013 [cited 2015 Jan 5]. Available from: http://www.ispor.org/congresses/Dublin1113/presentations/IP9-Solow.pdf
  7. Talsma J The PBM squeeze despite acute margin pressure, retail pharmacies fight to stay in the game Drug Topics 2013 [cited 2015 Sep 18]. Available from: http://drugtopics.modernmedicine.com/drug-topics/news/tags/mac/pbm-squeeze?contextCategoryId=106
  8. Rentmeester CA Garis RI Rebates and spreads: pharmacy benefit management practices and corporate citizenship Journal of Health Politics, Policy and Law 2008 33 5 943 63; 965–78 10.1215/03616878-2008-025
  9. Top 10 Pharmacy Benefit Management Companies and Market Share by Annual Prescription Volume, as of 2nd Quarter 2011, Pharmacy Benefit Management Institute 2012 [cited 2015 Sep 18]. Available from: http://pbmi-com.web33.winsvr.net/PBMmarketshare2.asp
  10. Armstrong D Forden S Express Scripts, Medco Win Approval for $29 Billion Deal, Bloomberg 2012 Apr 2 [cited 2014 Feb 24]. Available from: http://www.bloomberg.com/news/2012-04-02/express-scripts-medco-win-approval-for-29-billion-deal.html
  11. PricewaterhouseCoopers: pharmacy benefit management savings in Medicare and the commercial marketplace & the cost of proposed PBM legislation, 2008-2017 2007 [cited 2014 Feb 24]. Available from: http://www.pwc.com/us/en/national-economic-statistics/assets/pharma_savings_medicare_pbm_leg.pdf
  12. OECD Health at a glance: OECD indicators 2011 2011 Paris OECD Publishing [cited 2015 Jan 3]. Available from: http://www.oecd.org/els/health-systems/49105858.pdf
  13. DeArment A PBM tools slowed Rx spending growth in 2010 2011 [cited 2014 Feb 23]. Available from: http://drugstorenews.com/article/pbm-tools-slowed-rx-spending-growth-2010
  14. Coleman M Morrow C Does e-prescribing lower prices? Southwest medical associates found eRx helped arm physicians with pertinent information at the point of care Healthcare Informatics 2007 24 7 45 6
  15. Perrone M Electronic prescribing push clicks with congress 2008 Jun The Associated Press
  16. Dolan PL Prepare to meet “meaningful use” EMR requirement 2009 American Medical Association [cited 2014 Feb 22]. Available from: http://www.amednews.com/article/20090615/business/306159998/5/
  17. Edavalath E E-prescription: impending acceptance in Europe 2009 Frost & Sullivan [cited 2014 Feb 21]. Available from: https://www.frost.com/sublib/display-market-insight.do?id=163558282
  18. Burley C Electronic prescribing in 2011 Bulletin of the American College of Surgeons 2011 96 6 6 11
  19. Ketchersid T Electronic prescribing by the numbers Nephrol News Issues 2011 25 11 28 30
  20. Tanne JH Electronic prescribing could save at least $29bn BMJ 2004 328 7449 1155
  21. Technology Innovation, US Healthcare and Health Reforms 2011 Jul 25 [cited 2014 Feb 22]. Available from: http://thoughtsonhealthcare.wordpress.com/
  22. Haas JS Phillips KA Gerstenberger EP Seger AC Potential savings from substituting generic drugs for brand-name drugs: Medical expenditure panel survey, 1997-2000 Annals of Internal Medicine 2005 142 891 897
  23. Posner J Griffin JP Generic substitution British Journal of Clinical Pharmacology 2011 72 5 731 2
  24. Shrank WH Choudhry NK Agnew-Blais J Federman AD Liberman JN Liu J State generic substitution laws can lower drug outlays under medicaid Health Affairs 2010 29 7 1383 90
  25. Hieber KA Is your pharmacy benefit designed for your employees or the big drug companies? 2008 [cited 2015 Jan 3]. Available from: https://www.pbmplus.com/docs/Pharmacy_Benefit_Design.pdf
  26. Chmielewska M Czech M Drozdowska AK Faluta T Hermanowski T Kiljan A Zawodnik S Financing methods for pharmaceuticals. InterQuality project – Collaborative work report 2011
  27. Herrick DM Unnecessary regulations that increase prescription drug costs 2013 [cited 2015 Jan 3]. Available from: http://www.ncpa.org/pub/st346
  28. Doupi PE Renko SG Dumortier J Health strategies – Country Brief: Denmark 2010 [cited 2014 Feb 24]. Available from: http://ehealth-strategies.eu/database/documents/Denmark_CountryBrief_eHStrategies.pdf
  29. Strandberg-Larsen M Nielsen MB Vallgårda S Krasnik A Vrangbæk K Mossialos E Denmark: health system review Health Systems in Transition 2007 9 6 1 164
  30. Danish Health and Medicines Authority Generic substitution – questions and answers 2011 [cited 2014 Feb 24]. Available from: http://www.dkma.dk
  31. Pedersen MK Pricing and reimbursement of drugs in Denmark European Journal of Health Economics 2003 4 1 60 5
  32. Maximus England eHealth Solutions Available from: https://www.maximusuk.co.uk/health-programmes/ehealth-solutions
  33. Nguyen-Kim L Zeynep O Paris V Sermet C The politics of drug reimbursement in England, France and Germany. Issues in health economics No. 99, 2005 Oct. Paris, France Institute for Research and Information in Health Edonomics
  34. OECD Competition Committee Roundtable on generic pharmaceuticals. DAF/COMP(2009)39
  35. Jack A Generic substitution of drugs is set to be introduced in 2010 BMJ 2008 33 7 a2699
  36. Górecki P Slużba zdrowia na zwolnieniu Health service on release GazetaWyborcza 2014 12 14 15 [in Polish]
  37. Ustawa z dnia 28 kwietnia 2011 r. o systemie informacji w ochronie zdrowia The legal act about the information system in health care Warsaw Dziennik Ustaw, Kancelaria Sejmu Dz.U.11.113.657. [in Polish]
  38. Ministry of Health The project electronic platform collection analysis and dissemination of digital resources for medical events [cited 2014 Feb 24]. Available from: http://www.mz.gov.pl/en/development-and-investments/computerisation-in-healthcare/national-e-health-projects
  39. Center for Health Information Systems Centrum Systemów Informacyjnych Ochrony Zdrowia Center for Health Information Systems [O Centrum]. [cited 2014 Feb 24]. Available from: http://www.csioz.gov.pl/ocentrum.php. [in Polish].
  40. Tamburini ES Giest J Dumortier J Artmann J Health Strategies- Country Brief: Italy 2010 [cited 2014 Feb 24]. Available from: http://ehealth-strategies.eu/database/documents/Italy_CountryBrief_eHStrategies.pdf
  41. Italy – pharmaceuticals 2008 [cited 2014 Feb 24]. Available from: http://www.ispor.org/htaroadmaps/italy.asp
  42. Simoens S De Coster S Potential savings from increased substitution of generic for originator medicines in Europe Journal of Generic Medicines 2006 4 43 5
  43. Garau M Mestre-Ferrandiz J European medicines pricing and reimbursement 2006 Abingdon Radcliffe Publishing Ltd 72
  44. Generic Medicines 2005 Apr [cited 2014 Feb 25; updated 2007 Aug 3]. Available from: http://www.euractiv.com/health/generic-medicines/article-117497?display=normal
  45. Germany's national e-health programme: contested but driven forward [cited 2014 Feb 25]. Available from: http://www.ehealtheurope.net/Features/item.cfm?docId=189
  46. Stroetmann KA Artmann J Giest S Country brief: Germany [cited 2014 Feb 24]. Available from: http://ehealth-strategies.eu/database/documents/Germany_CountryBrief_eHS_12.pdf
  47. Weissenfeld J Stock S Lüngen M Gerber A The nocebo effect: a reason for patients’ non-adherence to generic substitution? Die Pharmazie 2010 65 7 451 6
  48. Hoffmann F Glaeske G Pfannkuche MS The effect of introducing rebate contracts to promote generic drug substitution, on doctors’ prescribing practices Deutsches Ärzteblatt International 2009 106 48 783 8
  49. OECD Reviews of Health Care Quality: Korea – Raising Standards, OECD Publishing [cited 2014 Feb 24]. Available from: http://dx.doi.org/10.1787/9789264173446-en
  50. Lee YH Kim SJ Kim GS Kim CU Yuk SM Kim SM Information system of nationwide DUR in Korea 2012 [cited 2014 Feb 25]. Available from: http://www.isqua.org/docs/geneva-presentations/bp5-2154-y-lee.pdf?sfvrsn=2
  51. Hermanowski T Ryć K Skrzypczak Z Udzial wlasny pacjenta jako metoda ograniczania pokusy nadużywania leków refundowanych Patient deductible as a way to reduce the temptation to abuse reimbursed drugs Ochrona Zdrowia i Gospodarka Health Care and Economy 2010 Warszawa WWZ – Uniwersytet Warszawski Wydzial Zarzadzania [in Polish]
DOI: https://doi.org/10.5334/ijic.2253 | Journal eISSN: 1568-4156
Language: English
Submitted on: Apr 14, 2014
Accepted on: Aug 19, 2015
Published on: Sep 29, 2015
Published by: Uopen Journals
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2015 Tomasz Roman Hermanowski, Aleksandra Krystyna Drozdowska, Marta Kowalczyk, published by Uopen Journals
This work is licensed under the Creative Commons Attribution 4.0 License.